Rhenman & Partners Asset Management AB as of June 30, 2015
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 96 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Index option | 8.9 | $74M | 200k | 368.97 | |
| Select Sector Spdr Tr option | 6.2 | $52M | 700k | 74.39 | |
| UnitedHealth (UNH) | 3.4 | $28M | 231k | 122.00 | |
| Alexion Pharmaceuticals | 2.9 | $24M | 133k | 180.77 | |
| Alkermes (ALKS) | 2.7 | $23M | 349k | 64.34 | |
| Biogen Idec (BIIB) | 2.4 | $20M | 50k | 403.95 | |
| CVS Caremark Corporation (CVS) | 2.3 | $19M | 184k | 104.88 | |
| Johnson & Johnson (JNJ) | 2.2 | $19M | 191k | 97.46 | |
| Cardinal Health (CAH) | 2.2 | $18M | 215k | 83.65 | |
| Celgene Corporation | 1.9 | $16M | 137k | 115.74 | |
| Abbvie (ABBV) | 1.9 | $16M | 233k | 67.19 | |
| Gilead Sciences (GILD) | 1.8 | $15M | 130k | 117.08 | |
| Rite Aid Corporation | 1.8 | $15M | 1.8M | 8.35 | |
| Merck & Co (MRK) | 1.8 | $15M | 260k | 56.93 | |
| Eli Lilly & Co. (LLY) | 1.8 | $15M | 175k | 83.49 | |
| Bristol Myers Squibb (BMY) | 1.6 | $13M | 198k | 66.54 | |
| Allergan | 1.5 | $13M | 42k | 303.45 | |
| BioMarin Pharmaceutical (BMRN) | 1.5 | $13M | 92k | 136.78 | |
| Jazz Pharmaceuticals (JAZZ) | 1.5 | $12M | 70k | 176.07 | |
| Nektar Therapeutics | 1.4 | $12M | 937k | 12.51 | |
| Medtronic (MDT) | 1.4 | $12M | 155k | 74.10 | |
| Incyte Corporation (INCY) | 1.4 | $11M | 108k | 104.21 | |
| Amgen (AMGN) | 1.3 | $11M | 69k | 153.52 | |
| Regeneron Pharmaceuticals (REGN) | 1.2 | $9.7M | 19k | 510.11 | |
| Cempra | 1.1 | $9.5M | 277k | 34.36 | |
| Anthem (ELV) | 1.1 | $9.5M | 58k | 164.14 | |
| Universal Health Services (UHS) | 1.1 | $9.2M | 65k | 142.11 | |
| Esperion Therapeutics (ESPR) | 1.1 | $9.2M | 112k | 81.76 | |
| Perrigo Company (PRGO) | 1.0 | $8.7M | 47k | 184.83 | |
| Laboratory Corp. of America Holdings | 1.0 | $8.5M | 70k | 121.21 | |
| Becton, Dickinson and (BDX) | 1.0 | $8.5M | 60k | 141.65 | |
| ACADIA Pharmaceuticals (ACAD) | 1.0 | $8.0M | 191k | 41.88 | |
| Cooper Companies | 0.9 | $7.3M | 41k | 177.98 | |
| Dex (DXCM) | 0.9 | $7.4M | 92k | 79.98 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $7.4M | 61k | 119.87 | |
| Valeant Pharmaceuticals Int | 0.9 | $7.2M | 32k | 222.15 | |
| Supernus Pharmaceuticals (SUPN) | 0.8 | $7.1M | 417k | 16.98 | |
| Express Scripts Holding | 0.8 | $7.0M | 79k | 88.94 | |
| Community Health Systems (CYH) | 0.8 | $6.9M | 110k | 62.97 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $6.8M | 55k | 123.47 | |
| Abiomed | 0.8 | $6.8M | 104k | 65.73 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $6.6M | 206k | 31.95 | |
| Aetna | 0.8 | $6.5M | 51k | 127.45 | |
| Hca Holdings (HCA) | 0.8 | $6.3M | 69k | 90.72 | |
| St. Jude Medical | 0.7 | $6.1M | 83k | 73.07 | |
| Cyberonics | 0.7 | $5.9M | 100k | 59.46 | |
| Intercept Pharmaceuticals In | 0.7 | $5.8M | 24k | 241.38 | |
| Cerner Corporation | 0.7 | $5.7M | 83k | 69.06 | |
| Mylan Nv | 0.7 | $5.6M | 83k | 67.86 | |
| McKesson Corporation (MCK) | 0.7 | $5.6M | 25k | 224.80 | |
| Revance Therapeutics | 0.7 | $5.5M | 172k | 31.98 | |
| Teva Pharmaceutical Industries (TEVA) | 0.7 | $5.4M | 92k | 59.10 | |
| ISIS Pharmaceuticals | 0.7 | $5.4M | 94k | 57.55 | |
| Keryx Biopharmaceuticals | 0.6 | $5.3M | 534k | 9.98 | |
| Clovis Oncology | 0.6 | $5.3M | 61k | 87.88 | |
| Receptos | 0.6 | $5.3M | 28k | 190.04 | |
| Anthera Pharmaceutcls | 0.6 | $5.3M | 620k | 8.62 | |
| Medivation | 0.6 | $5.3M | 46k | 114.20 | |
| Tetraphase Pharmaceuticals | 0.6 | $5.1M | 107k | 47.44 | |
| Lion Biotechnologies | 0.6 | $5.1M | 556k | 9.17 | |
| Celldex Therapeutics | 0.6 | $5.0M | 197k | 25.22 | |
| Thoratec Corporation | 0.6 | $4.9M | 110k | 44.57 | |
| AmSurg | 0.6 | $4.9M | 70k | 69.96 | |
| Thermo Fisher Scientific (TMO) | 0.6 | $4.8M | 37k | 129.76 | |
| Endo International | 0.6 | $4.7M | 59k | 79.64 | |
| AmerisourceBergen (COR) | 0.5 | $4.5M | 42k | 106.33 | |
| Centene Corporation (CNC) | 0.5 | $4.3M | 54k | 80.41 | |
| Xencor (XNCR) | 0.5 | $4.1M | 188k | 21.97 | |
| Macrogenics (MGNX) | 0.5 | $4.1M | 108k | 37.97 | |
| Edwards Lifesciences (EW) | 0.5 | $4.0M | 28k | 142.43 | |
| Kite Pharma | 0.5 | $4.0M | 66k | 60.97 | |
| Orexigen Therapeutics | 0.5 | $3.9M | 789k | 4.95 | |
| Halozyme Therapeutics (HALO) | 0.5 | $3.9M | 172k | 22.58 | |
| Zeltiq Aesthetics | 0.5 | $3.8M | 129k | 29.47 | |
| Ariad Pharmaceuticals | 0.5 | $3.7M | 450k | 8.27 | |
| Hologic (HOLX) | 0.4 | $3.5M | 93k | 38.06 | |
| Portola Pharmaceuticals | 0.4 | $3.5M | 76k | 45.55 | |
| Catabasis Pharmaceuticals | 0.4 | $3.2M | 265k | 12.21 | |
| Epizyme | 0.4 | $3.2M | 132k | 24.00 | |
| Cepheid | 0.4 | $3.1M | 51k | 61.16 | |
| Chimerix (CMRX) | 0.4 | $3.0M | 66k | 46.20 | |
| Rigel Pharmaceuticals | 0.4 | $3.0M | 925k | 3.21 | |
| Tesaro | 0.4 | $3.0M | 51k | 58.78 | |
| Dynavax Technologies (DVAX) | 0.3 | $2.9M | 123k | 23.42 | |
| Omnicell (OMCL) | 0.3 | $2.8M | 74k | 37.72 | |
| Insulet Corporation (PODD) | 0.3 | $2.8M | 90k | 30.99 | |
| Endologix | 0.3 | $2.7M | 179k | 15.34 | |
| Array BioPharma | 0.3 | $2.7M | 370k | 7.21 | |
| Achillion Pharmaceuticals | 0.3 | $2.5M | 280k | 8.86 | |
| Avalanche Biotechnologies In | 0.3 | $2.5M | 154k | 16.24 | |
| Tandem Diabetes Care | 0.3 | $2.3M | 209k | 10.84 | |
| Mirati Therapeutics | 0.2 | $1.6M | 50k | 31.48 | |
| Lexicon Pharmaceuticals (LXRX) | 0.2 | $1.4M | 171k | 8.05 | |
| HeartWare International | 0.1 | $1.1M | 16k | 72.68 | |
| Threshold Pharmaceuticals | 0.1 | $814k | 202k | 4.04 | |
| Bind Therapeutics | 0.1 | $747k | 134k | 5.59 |
